Mimedx Group Stock Alpha and Beta Analysis
| MDXG Stock | USD 5.09 0.12 2.30% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MiMedx Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in MiMedx over a specified time horizon. Remember, high MiMedx's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MiMedx's market risk premium analysis include:
Beta 0.91 | Alpha (0.62) | Risk 2.2 | Sharpe Ratio (0.24) | Expected Return (0.53) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out MiMedx Analysis, MiMedx Valuation, MiMedx Correlation, MiMedx Hype Analysis, MiMedx Volatility, MiMedx Price History and analyze MiMedx Performance. MiMedx Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MiMedx market risk premium is the additional return an investor will receive from holding MiMedx long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MiMedx. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MiMedx's performance over market.| α | -0.62 | β | 0.91 |
MiMedx expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of MiMedx's Buy-and-hold return. Our buy-and-hold chart shows how MiMedx performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.MiMedx Market Price Analysis
Market price analysis indicators help investors to evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MiMedx shares will generate the highest return on investment. By understating and applying MiMedx stock market price indicators, traders can identify MiMedx position entry and exit signals to maximize returns.
MiMedx Return and Market Media
The median price of MiMedx for the period between Sat, Nov 15, 2025 and Fri, Feb 13, 2026 is 6.72 with a coefficient of variation of 13.23. The daily time series for the period is distributed with a sample standard deviation of 0.84, arithmetic mean of 6.36, and mean deviation of 0.74. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | MiMedx Group Stock Price Down 5.6 percent Whats Next | 11/18/2025 |
2 | Can MiMedx Group Inc. stock maintain operating margins - Sell Signal Growth Oriented Trading Recommendations - | 12/18/2025 |
3 | Harbor Capital Advisors Inc. Cuts Holdings in MiMedx Group, Inc MDXG - MarketBeat | 12/26/2025 |
4 | MiMedx Group Inc Is Quietly Going Off Is MDXG the Sleeper Stock Youre Sleeping On - AD HOC NEWS | 01/06/2026 |
5 | MiMedx Group, Inc Stock Analysis A Biotech Gem With 96.67 percent Upside Potential - DirectorsTalk Interviews | 01/13/2026 |
6 | Acquisition by Behrens M Kathleen of 28609 shares of MiMedx at 6.47 subject to Rule 16b-3 | 01/15/2026 |
7 | Recent 8.9 percent pullback isnt enough to hurt long-term MiMedx Group shareholders, theyre still up 70 percent over 3 years | 01/16/2026 |
8 | How The New Price Target Is Shaping The Story For MiMedx Group | 01/22/2026 |
9 | MiMedx Group, Inc Stock Analysis Significant Upside with 98.10 percent Potential Growth Awaits Investors - directorstalkinterviews.com | 01/27/2026 |
10 | MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical Wound Products | 02/04/2026 |
11 | Insider Trading | 02/09/2026 |
About MiMedx Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MiMedx or other stocks. Alpha measures the amount that position in MiMedx Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 61.16 | 58.41 | 67.17 | 72.28 | PTB Ratio | 7.16 | 7.32 | 8.42 | 8.0 |
MiMedx Upcoming Company Events
As portrayed in its financial statements, the presentation of MiMedx's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MiMedx's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MiMedx's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MiMedx. Please utilize our Beneish M Score to check the likelihood of MiMedx's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with MiMedx
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out MiMedx Analysis, MiMedx Valuation, MiMedx Correlation, MiMedx Hype Analysis, MiMedx Volatility, MiMedx Price History and analyze MiMedx Performance. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.